Treatment of esthesioneuroblastoma: A 16-year meta-analysis of 361 patients

Laryngoscope

Volumn 119, Issue 7, 2009, Pages 1412-1416

  Devaiah, Anand K ^a,b   Andreoli, Michael T ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Craniofacial; Endoscopic; Esthesioneuroblastoma; Metaanalysis; Olfactory neuroblastoma

Indexed keywords

ARTICLE; CANCER STAGING; CLINICAL TRIAL; ENDOSCOPIC SURGERY; ESTHESIONEUROBLASTOMA; FOLLOW UP; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ENDOSCOPY; ESTHESIONEUROBLASTOMA, OLFACTORY; HUMANS; NASAL CAVITY; NEOPLASM STAGING; NOSE NEOPLASMS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 67949114026     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20280     Document Type: Article

References (54)

1. Kadish S., Goodman M., Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976; 37: 1571-1576.
2. Biller HF, Lawson W., Sachdev VP, Som P. Esthesioneuroblastoma: surgical treatment without radiation. Laryngoscope 1990; 100:1199-1201.
3. Dulguerov P., Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 1992; 102: 843-849.
4. Resto VA, Eisele DW, Forastiere A., Zahurak M., Lee DJ, Westra WH. Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck 2000; 22:550-558.
5. Gruber G., Laedrach K., Baumert B., Caversaccio M., Raveh J., Greiner R. Esthesioneuroblastoma: irradiation alone and surgery alone are not enough. Int J Radiat Oncol Biol Phys 2002; 54:486-491.
6. Dulguerov P., Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2001; 2: 683-690.
7. Argiris A., Dutra J., Tseke P., Haines K. Esthesioneuroblastoma: the Northwestern University experience. Laryngoscope 2003; 113:155-160.
8. Kim HJ, Cho HJ, Kim KS, Lee HS, Jung E., Yoon JH. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma. J Craniomaxillofac Surg 2008; 36:47-52.
9. Eich HT, Staar S., Micke O., Eich PD, Stutzer H., Muller R. Radiotherapy of esthesioneuroblastoma. Int J Radiat Oncol Biol Phys 2001; 49:155-160.
10. McLean JN, Nunley SR, Klass C., Moore C., Muller S., Johnstone PA. Combined modality therapy of esthesioneuroblastoma. Otolaryngol Head Neck Surg 2007; 136: 998-1002.
11. Monroe AT, Hinerman RW, Amdur RJ, Morris CG, Mendenhall WM. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head Neck 2003; 25:529-534.
12. Dias FL, Sa GM, Lima RA, et al. Patterns of failure and outcome in esthesioneuroblastoma. Arch Otolaryngol Head Neck Surg 2003; 129:1186-1192.
13. Chao KS, Kaplan C., Simpson JR, et al. Esthesioneuroblastoma: the impact of treatment modality. Head Neck 2001; 23:749-757.
14. Irish J., Dasgupta R., Freeman J., et al. Outcome and analysis of the surgical management of esthesioneuroblastoma. J Otolaryngol 1997; 26:1-7.
15. Diaz EM Jr, Johnigan RH III, Pero C., et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck 2005; 27:138-149.
16. Richtsmeier WJ, Briggs RJ, Koch WM, et al. Complications and early outcome of anterior craniofacial resection. Arch Otolaryngol Head Neck Surg 1992; 118:913-917.
17. Koopman L., van der Heijden GJ, Hoes AW, Grobbee DE, Rovers MM. Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses. Int J Technol Assess Health Care 2008; 24:358-361.
18. Zafereo ME, Fakhri S., Prayson R., et al. Esthesioneuroblastoma: 25-year experience at a single institution. Otolaryngol Head Neck Surg 2008; 138:452-458.
19. Kiyota N., Tahara M., Fujii S., et al. Nonplatinum-based chemotherapy with irinotecan plus docetaxel for advanced or metastatic olfactory neuroblastoma: a retrospective analysis of 12 cases. Cancer 2008; 112:885-891.
20. Dave SP, Bared A., Casiano RR. Surgical outcomes and safety of transnasal endoscopic resection for anterior skull tumors. Otolaryngol Head Neck Surg 2007; 136: 920-927.
21. Rastogi M., Bhatt M., Chufal K., et al. Esthesioneuroblastoma treated with non-craniofacial resection surgery followed by combined chemotherapy and radiotherapy: an alternative approach in limited resources. Jpn J Clin Oncol 2006; 36:613-619.
22. Unger F., Haselsberger K., Walch C., Stammberger H., Papaefthymiou G. Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma). Acta Neurochir (Wien) 2005; 147:595-601.
23. Yuen AP, Fan YW, Fung CF, Hung KN. Endoscopic-assisted cranionasal resection of olfactory neuroblastoma. Head Neck 2005; 27:488-493.
24. Wang CC, Chen YL, Hsu YS, Jung SM, Hao SP. Transcranial resection of olfactory neuroblastoma. Skull Base 2005; 15:163-171.
25. Poetker DM, Toohill RJ, Loehrl TA, Smith TL. Endoscopic management of sinonasal tumors: a preliminary report. Am J Rhinol 2005; 19:307-315.
26. Mishima Y., Nagasaki E., Terui Y., et al. Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous-infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with esthesioneuroblastoma. Cancer 2004; 101:1437-1444.
27. Constantinidis J., Steinhart H., Koch M., et al. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000. Otolaryngol Head Neck Surg 2004; 130: 567-574.
28. Devaiah AK, Larsen C., Tawfik O., O'Boynick P., Hoover LA. Esthesioneuroblastoma: endoscopic nasal and anterior craniotomy resection. Laryngoscope 2003; 113:2086-2090.
29. Eich HT, Hero B., Staar S., et al. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma. Strahlenther Onkol 2003; 179:233-240.
30. Hwang SK, Paek SH, Kim DG, Jeon YK, Chi JG, Jung HW. Olfactory neuroblastomas: survival rate and prognostic factor. J Neurooncol 2002; 59:217-226.
31. Chamberlain MC. Treatment of intracranial metastatic esthesioneuroblastoma. Cancer 2002; 95:243-248.
32. Simon JH, Zhen W., McCulloch TM, et al. Esthesioneuroblastoma: the University of Iowa experience 1978-1998. Laryngoscope 2001; 111:488-493.
33. Eriksen JG, Bastholt L., Krogdahl AS, Hansen O., Joergensen KE. Esthesioneuroblastoma-what is the optimal treatment? Acta Oncol 2000; 39:231-235.
34. Slevin NJ, Irwin CJ, Banerjee SS, Gupta NK, Farrington WT Olfactory neural tumours-the role of external beam radiotherapy. J Laryngol Otol 1996; 110:1012-1016.
35. Castelnuovo P., Bignami M., Delu G., Battaglia P., Bignardi M., Dalian I. Endonasal endoscopic resection and radiotherapy in olfactory neuroblastoma: our experience. Head Neck 2007; 29:845-850.
36. Suriano M., De Vincentiis M., Colli A., Benfari G., Mascelli A., Gallo A. Endoscopic treatment of esthesioneuroblastoma: a minimally invasive approach combined with radiation therapy. Otolaryngol Head Neck Surg 2007; 136:104-107.
37. Jethanamest D., Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg 2007; 133:276-280.
38. Daly ME, Chen AM, Bucci MK, et al. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 2007; 67:151-157.
39. Zhang LW, Zhang MS, Qi J., et al. Management of intracranial invasive olfactory neuroblastoma. Chin Med J (Engl) 2007; 120:224-227.
40. Nishimura H., Ogino T., Kawashima M., et al. Proton-beam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys 2007; 68:758-762.
41. Loy AH, Reibel JF, Read PW, et al. Esthesioneuroblastoma: continued follow-up of a single institution's experience. Arch Otolaryngol Head Neck Surg 2006; 132:134-138.
42. Buchmann L., Larsen C., Pollack A., Tawfik O., Sykes K., Hoover LA. Endoscopic techniques in resection of anterior skull base/paranasal sinus malignancies. Laryngoscope 2006; 116:1749-1754.
43. Eich HT, Muller RP, Micke O., Kocher M., Berthold F., Hero B. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment? Strahlenther Onkol 2005; 181:378-384.
44. Kim DW, Jo YH, Kim JH, et al. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer 2004; 101:2257-2260.
45. Bentz BG, Bilsky MH, Shah JP, Kraus D. Anterior skull base surgery for malignant tumors: a multivariate analysis of 27 years of experience. Head Neck 2003; 25: 515-520.
46. Ingeholm P., Theilgaard SA, Buchwald C., Hansen HS, Francis D. Esthesioneuroblastoma: a Danish clinicopathological study of 40 consecutive cases. APMIS 2002; 110: 639-645.
47. Cantu G., Solero CL, Mariani L., et al. Anterior craniofacial resection for malignant ethmoid tumors-a series of 91 patients. Head Neck 1999; 21:185-191.
48. Koka VN, Julieron M., Bourhis J., et al. Aesthesioneuroblastoma. J Laryngol Otol 1998; 112:628-633.
49. Lund VJ, Howard DJ, Wei WI, Cheesman AD. Craniofacial resection for tumors of the nasal cavity and paranasal sinuses-a 17-year experience. Head Neck 1998; 20: 97-105.
50. Bhattacharyya N., Thornton AF, Joseph MP, Goodman ML, Amrein PC. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Results in 9 cases. Arch Otolaryngol Head Neck Surg 1997; 123:34-40.
51. Morita A., Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993; 32:706-714.
52. Butugan O., Bogar P., Sennes LU, et al. Olfactory neuroblastoma. A report of 5 cases. Rev Laryngol Otol Rhinol (Bord) 1993; 114:359-363.
53. McElroy EA Jr, Buckner JC, Lewis JE. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery 1998; 42:1023-1027; discussion 1027-1028.
54. Casiano RR, Numa WA, Falquez AM. Endoscopic resection of esthesioneuroblastoma. Am J Rhinol 2001; 15:271-279.